GT Biopharma (GTBP) ended 2024 with roughly $4M in cash, enough to fund operations into the second quarter of 2025, Roth MKM tells investors in ...

When a test determined that Walter had hemophilia, his Omaha owner joined a group seeking to raise $50,000 for a clinical ...

Although this initial study was not intended to measure sensor accuracy, Glucotrack noted that the system performed as ...

United Therapeutics shows strong revenue growth, driven by Tyvaso, and maintains high margins and low debt burden. Read why I ...

Summit Therapeutics established a clinical trial collaboration with Pfizer to develop ivonescimab for NSCLC and solid tumors.

Illumina, Inc. ILMN recently entered into a collaboration with Broad Clinical Labs to rapidly streamline and scale single-cell projects with cutting-edge tools and workflows. Together, the companies ...

With A$AP Rocky’s Ray-Ban moments, courtroom style has become a cultural phenomenon, blending law, fashion, and branding into ...

Three of Australia's most successful global life sciences plays have reported increased interim profits – with the promise of ...

The first of Opthea’s (ASX:OPT) two phase III eye disease trials has hit a key development milestone, with the last patient ...

A reporter uncovers evidence that research fraud on a massive scale has hyped the potential benefit of expensive drugs aimed at slowing or reversing the mental decline of patients with Alzheimer’s ...

According to an announcement from the Museum of Natural History, the "perfectly timed capture" was one of 25 images selected by the museum and an international panel of judges for the 60th annual ...